Cited by 23Urticaria and Related ConditionsMobile Health and mHealth ApplicationsDigital Mental Health Interventions

Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis

Open access
Cherrez‐Ojeda, Ivan, Vanegas, Emanuel, Cherrez, Annia, Felix, Miguel, Weller, Karsten, Magerl, Markus, Maurer, Rasmus Robin, Mata, Valeria L. +29 more·2021·Clinical and Translational Allergy

Abstract

Background: Information/communication technologies such as mobile phone applications (apps) would enable chronic urticaria (CU) patients to self‐evaluate their disease activity and control. Yet, recently Antó et al (2021) reported a global paucity of such apps for patients with CU. In this analysis, we assessed patient interest in using apps to monitor CU disease activity and control using questions from the chronic urticaria information and communication technologies (CURICT) study. Methods: The methodology for CURICT has been reported. Briefly, a 23‐item questionnaire was completed by 1841 CU patients from 17 UCAREs across 17 countries. Here, we analyzed patient responses to the CURICT questions on the use of apps for urticaria‐related purposes. Results: As previously published, the majority of respondents had chronic spontaneous urticaria (CSU; 63%; 18% chronic inducible urticaria (CIndU) [CIndu]; 19% with both), were female (70%) and in urban areas (75%). Over half of patients were very/extremely interested in an app to monitor disease activity (51%) and control (53%), while only ∼1/10 were not. Patients with both urticaria types versus those with CSU only (odds ratio [OR], 1.36 [1.03–1.79]) and females versus males (OR [95% CI], 1.47 [1.17–1.85]) were more likely to be very to extremely interested in an app to assess disease control. Conclusions: Overall, half of the patients with CU were very to extremely interested in using an app to assess their disease activity and control. Development of well‐designed apps, specific to disease types (CSU, CIndU, CSU + CIndU, etc), validated by experts across platforms would help improve the management and possibly outcomes of CU treatment while providing important patient information to be used in future research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/clt2.12089

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 8 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Cherrez‐Ojeda, I., Vanegas, E., Cherrez, A., Felix, M., Weller, K., Magerl, M., Maurer, R. R., Mata, V. L., Kasperska‐Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Rao, N. D., Khoshkhui, M., Rastgoo, S., Criado, R. F. J., Abuzakouk, M., Grandon, D., Van Doorn, M. B. A., Rodrigues Valle, S. O., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Matos Benavides, E. E., Bauer, A., Giménez‐Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., & Maurer, M.
Affiliations
  • Universidad Espíritu Santo Samborondón Ecuador
  • Universidad Espíritu Santo (EC)
  • Respiralab Respiralab Research Group Guayaquil Ecuador
  • Humboldt-Universität zu Berlin (DE)
  • European Center for Diagnosis and Treatment of Urticaria Medical University of Silesia Katowice Poland
  • Medical University of Silesia (PL)
  • Sechenov University (RU)
  • City Center of Allergy and Immunology Clinical City Hospital #52 Moscow Russia
  • DY Patil Deemed to be University (IN)
  • Mashhad University of Medical Sciences (IR)
  • Faculdade de Medicina do ABC (BR)
  • Cleveland Clinic Abu Dhabi (AE)
  • Department of Dermatology Erasmus MC Rotterdam The Netherlands
  • Department of Internal Medicine Hospital Universitário Clementino Fraga Filho Rio de Janeiro Brazil
  • Faculty of Science and Health of Juiz de Fora ‐ SUPREMA ‐ Minas Gerais Rio de Janeiro Brazil
  • University of Copenhagen (DK)
  • Instituto de Alergia e Inmunología del Sur, Bahía Blanca Buenos Aires Argentina
  • Centro de Referencia de Alergia Asma e Inmunología ‐ Instituto Nacional del Niño Lima Peru
  • University Hospital Carl Gustav Carus (DE)
  • Universitat Autònoma de Barcelona (ES)
  • Koç University (TR)
  • University Hospital Zurich (CH)
  • Allergy Department Clinica San Felipe Lima Peru
  • Department of Dermatology and Venereology Peking University First Hospital Beijing China
  • National and Kapodistrian University of Athens (GR)
  • Hospital Italiano de Buenos Aires (AR)
  • Federal University of São Paulo São Paulo Brazil
Venue
Clinical and Translational Allergy
Publisher
Wiley
Published
2021-12
Volume
11
Issue
10
Pages
e12089-e12089
ISSN
2045-7022 (ISSN-L)
OpenAlex
W4200153944
Cited by
23
References
8
Citations by year
2026: 3 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 2
FWCI
2.62
Type
journal article
Language
en
Open access
Locations
  • Clinical and Translational Allergy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Collections portal (Koç University) (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion, other-oa)
  • Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Rheumatology › Urticaria and Related Conditions
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
chronic urticaria, mobile health apps, patient interests, disease activity monitoring, disease control, chronic spontaneous urticaria, chronic inducible urticaria, patient-reported outcomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review